The European Medicines Agency's strategies to meet the challenges of Alzheimer disease

Manuel Haas,Valentina Mantua,Marion Haberkamp,Luca Pani,Maria Isaac,Florence Butlen-Ducuing,Spiros Vamvakas,Karl Broich

NATURE REVIEWS DRUG DISCOVERY（2015）

引用 13|浏览6

暂无评分

摘要

Regulatory agencies have a key role in facilitating the development of new drugs for Alzheimer disease, particularly given the challenges associated with early intervention. Here, we summarize the strategies of the European Medicines Agency to help address such challenges.

查看译文

关键词

Clinical trials, Drug regulation, Biomarkers, Drug development, Diseases of the nervous system

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要